Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
ROCKEFELLER CAPITAL MANAGEMENT LP | 02-14-2024 | 12-31-2023 | 2960 | 29,927,421,348 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
INVESCO EXCH TRADED FD TR II | CALIF AMT MUN | 2051 | $271,344 | 10,862 | 0.00 | 10,862 | +Inf | 12-31-2023 | |
INVESCO EXCH TRADED FD TR II | FTSE RAFI EMNG | 2052 | $270,611 | 14,168 | 0.00 | 14,168 | +Inf | 12-31-2023 | |
CATALYST PHARMACEUTICALS INC | COM | 2053 | $270,002 | 16,062 | 0.00 | 16,062 | +Inf | 12-31-2023 | |
INVESCO EXCH TRADED FD TR II | FLOATING RATE MU | Liquidated | $0 | 0 | 0.00 | 10,863 | +Inf | 12-31-2023 |